Eloxx Pharmaceuticals, Inc.
ELOX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001035354
No open-market purchases or sales by Eloxx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Eloxx Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 47 | 41 | −6 |
| Shares | 16.7M | 16.1M | −563.6K (−3.4%) |
| Value | $33.2M | $26.0M | −$7.14M (−21.5%) |
New holders (8)
Institutions that held Eloxx Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Natixis | 103,900 | $170.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 63,698 | $104.0K | 0.00% |
| Private Advisor Group, LLC | 32,510 | $52.0K | 0.00% |
| Goldman Sachs Group Inc | 27,588 | $45.0K | 0.00% |
| Price T Rowe Associates Inc | 22,700 | $37.0K | 0.00% |
| ExodusPoint Capital Management, LP | 19,720 | $32.0K | 0.00% |
| Sawtooth Solutions, LLC | 16,201 | $26.0K | 0.00% |
| FMR LLC | 338 | $1.00K | 0.00% |
Sold out (14)
Institutions that held Eloxx Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Charles Schwab Investment Management Inc | 367,062 | $731.0K |
| Renaissance Technologies LLC | 163,900 | $326.0K |
| Ergoteles LLC | 121,900 | $243.0K |
| Cubist Systematic Strategies, LLC | 83,344 | $166.0K |
| HRT Financial LP | 74,056 | $147.0K |
| Deutsche Bank AG | 68,000 | $135.0K |
| Gratia Capital, LLC | 50,000 | $100.0K |
| XTX Topco Ltd | 46,884 | $93.0K |
| LMR Partners LLP | 14,435 | $29.0K |
| Royal Bank of Canada | 12,034 | $24.0K |
| UBS Group AG | 11,635 | $23.0K |
| Tower Research Capital LLC (TRC) | 10,612 | $21.0K |
| Jane Street Group, LLC | 10,587 | $21.0K |
| New York State Common Retirement Fund | 228 | $0 |